03.10.15
Galway, Ireland-based Proxy Biomedical Ltd., which makes biomaterials, has introduced Proxy Bio-XT, a strength-reinforcing technology for resorbable orthopedic products. The process is reported to optimize the microstructure of biomaterials to increase strength of the materials considerably.
“Resorbable implants present a number of clinical benefits for orthopaedic applications but their relatively low inherent strength presents a barrier to new product design and limits the adoption of resorbables in new indications,” said Kieran Moloney, vice president of engineering, Proxy Biomedical. “Proxy Bio-XT presents an excellent opportunity to substantially improve the performance of the resorbable implants that are currently on the market.”
Performance gains resulting from Proxy Bio-XT are enabled through maximization of the biomaterials’ inherent mechanical properties, which the company claims can be compromised during standard processes such as injection molding and extrusion. Results reported by Proxy Biomaterials indicate that resorbable implants manufactured using Bio-XT were significantly stronger than predicate devices of identical geometry and material grade, with a torsional strength increase of 102 percent.
Bio-XT is designed for application in any resorbable polymer or biocomposite blend, enabling its use for improvements to existing product families that leverage material grades that are well understood by the clinical and regulatory community.
“Resorbable implants present a number of clinical benefits for orthopaedic applications but their relatively low inherent strength presents a barrier to new product design and limits the adoption of resorbables in new indications,” said Kieran Moloney, vice president of engineering, Proxy Biomedical. “Proxy Bio-XT presents an excellent opportunity to substantially improve the performance of the resorbable implants that are currently on the market.”
Performance gains resulting from Proxy Bio-XT are enabled through maximization of the biomaterials’ inherent mechanical properties, which the company claims can be compromised during standard processes such as injection molding and extrusion. Results reported by Proxy Biomaterials indicate that resorbable implants manufactured using Bio-XT were significantly stronger than predicate devices of identical geometry and material grade, with a torsional strength increase of 102 percent.
Bio-XT is designed for application in any resorbable polymer or biocomposite blend, enabling its use for improvements to existing product families that leverage material grades that are well understood by the clinical and regulatory community.